ReviewJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2011
Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.
Review in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 44 citations in OpenAlex.
- Long-term survival and durable recovery of heart failure in patients with triglyceride deposit cardiomyovasculopathy treated with tricaprin.Nature cardiovascular research · 2025Article
- Cardiovascular imaging in cardio-oncology.Japanese journal of radiology · 2024Review
- Practice recommendation for measuring washout rates inAnnals of nuclear medicine · 2024Article
- Current status and perspectives of nuclear cardiology.Annals of nuclear medicine · 2024Review
- Synthesis and Preliminary Evaluation of anMolecular imaging and biology · 2023Article
- Practice Recommendation for Measuring Washout Rates inAnnals of nuclear cardiology · 2023Review
- Article
- Imaging Metabolically Active Fat: A Literature Review and Mechanistic Insights.International journal of molecular sciences · 2019Review
- Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015Review
- Molecular imaging of brown adipose tissue in health and disease.European journal of nuclear medicine and molecular imaging · 2014Review
- Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.European journal of nuclear medicine and molecular imaging · 2014Review
- LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment.European journal of nuclear medicine and molecular imaging · 2012Article
- Myocardial perfusion scintigraphy: past, present and future.The British journal of radiology · 2011Review
- Newer applications of nuclear cardiology in systolic heart failure: detecting coronary artery disease and guiding device therapy.Current heart failure reports · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the rapid growth of molecular biology, in vivo imaging of such molecular process (i.e., molecular imaging) has been well developed. The molecular imaging has been focused on justifying advanced treatments and for assessing the treatment effects. Most of molecular imaging has been developed using PET camera and suitable PET radiopharmaceuticals. However, this technique cannot be widely available and we need alternative approach. ¹²³I-labeled compounds have been also suitable for molecular imaging using single-photon computed tomography (SPECT) ¹²³I-labeled meta-iodobenzylguanidine (MIBG) has been used for assessing severity of heart failure and prognosis. In addition, it has a potential role to predict fatal arrhythmia, particularly for those who had and are planned to receive implantable cardioverter-defibrillator treatment. ¹²³I-beta-methyl-iodophenylpentadecanoic acid (BMIPP) plays an important role for identifying ischemia at rest, based on the unique capability to represent persistent metabolic alteration after recovery of ischemia, so called ischemic memory. Since BMIPP abnormalities may represent severe ischemia or jeopardized myocardium, it may permit risk analysis in CAD patients, particularly for those with chronic kidney disease and/or hemodialysis patients. This review will discuss about recent development of these important iodinated compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.